A jab that could protect against HIV for a year at a time, and other highlights from major conference

Posted in: Access to Medicines, Focus, Healthcare system, HIV/AIDS, InFocus, Latest, Spotlight

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV infection for as long as a year. Elri Voigt reports on this and some of the other exciting research on long-acting anti-HIV medicines presented at the Conference on Retroviruses and Opportunistic Infections.

A jab that could protect against HIV for a year at a time, and other highlights from major conference

Community care model improves uptake of TB preventive therapy, KZN study finds

Posted in: Latest, TB

The uptake and continuation of tuberculosis preventive therapy were much higher when it was provided through a community-based model compared to the standard clinic-based model, a study conducted in KwaZulu-Natal found. Elri Voigt unpacks the study findings, which were recently presented at the Conference for Retroviruses and Opportunistic Infections in Seattle, USA.